These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26360272)

  • 21. [Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
    Sewell RA; Skosnik PD; Garcia-Sosa I; Ranganathan M; D'Souza DC
    Braz J Psychiatry; 2010 May; 32 Suppl 1():S15-30. PubMed ID: 20512267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Why do patients with psychosis use cannabis and are they ready to change their use?
    Kolliakou A; Joseph C; Ismail K; Atakan Z; Murray RM
    Int J Dev Neurosci; 2011 May; 29(3):335-46. PubMed ID: 21172414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Letter to the Editor: Disentangling cause and effect in the relationship between cannabis and psychosis: are we there yet?
    Rentzsch J; Koller K; Kronenberg G
    Psychol Med; 2016 Oct; 46(14):3061-3062. PubMed ID: 27452108
    [No Abstract]   [Full Text] [Related]  

  • 24. Understanding the Link Between Cannabinoids and Psychosis.
    Rabin RA; George TP
    Clin Pharmacol Ther; 2017 Feb; 101(2):197-199. PubMed ID: 27367612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cannabis and Psychosis Through the Lens of DSM-5.
    Pearson NT; Berry JH
    Int J Environ Res Public Health; 2019 Oct; 16(21):. PubMed ID: 31661851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoids and psychosis.
    D'Souza DC
    Int Rev Neurobiol; 2007; 78():289-326. PubMed ID: 17349865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 'Cannabis-induced psychosis' may obscure paranoid schizophrenia.
    Saxena S
    Natl Med J India; 1993; 6(2):78-9. PubMed ID: 8477216
    [No Abstract]   [Full Text] [Related]  

  • 29. Cannabis and psychosis/schizophrenia: human studies.
    D'Souza DC; Sewell RA; Ranganathan M
    Eur Arch Psychiatry Clin Neurosci; 2009 Oct; 259(7):413-31. PubMed ID: 19609589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis and Neuropsychiatry, 2: The Longitudinal Risk of Psychosis as an Adverse Outcome.
    Andrade C
    J Clin Psychiatry; 2016 Jun; 77(6):e739-42. PubMed ID: 27337422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabis and risk of psychosis.
    Drewe M; Drewe J; Riecher-Rössler A
    Swiss Med Wkly; 2004 Nov; 134(45-46):659-63. PubMed ID: 15611887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clarifying the link between cannabis use and risk for psychosis.
    Weiss SRB; Blanco C; Wargo EM
    Acta Psychiatr Scand; 2017 Jul; 136(1):3-4. PubMed ID: 28556886
    [No Abstract]   [Full Text] [Related]  

  • 34. Cannabis consumption and psychosis or schizophrenia development.
    Ortiz-Medina MB; Perea M; Torales J; Ventriglio A; Vitrani G; Aguilar L; Roncero C
    Int J Soc Psychiatry; 2018 Nov; 64(7):690-704. PubMed ID: 30442059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The role of cannabis use in psychosis].
    Pajkossy P; Demetrovics Z
    Psychiatr Hung; 2007; 22(2):145-62. PubMed ID: 17895537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis-induced psychosis associated with high potency "wax dabs".
    Pierre JM; Gandal M; Son M
    Schizophr Res; 2016 Apr; 172(1-3):211-2. PubMed ID: 26876313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
    Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
    Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabis-associated psychosis with hypomanic features.
    Rottanburg D; Robins AH; Ben-Arie O; Teggin A; Elk R
    Lancet; 1982 Dec; 2(8312):1364-6. PubMed ID: 6129463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in associations between cannabis and stimulant disorders in first admission psychosis.
    Sara G; Burgess P; Malhi GS; Whiteford H; Hall W
    Schizophr Res; 2013 Jul; 147(2-3):216-22. PubMed ID: 23684162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.